Issue 9, 2018
From the journal:

MedChemComm

Correction: Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists

Yongkai Cao,abc   Ningning Sun,b   Jiumei Zhang,c   Zhiguo Liu,d   Yi-zhe Tang,c   Zhengzhi Wu,*c   Kyeong-Man Kim*b  and  Seung Hoon Cheon ORCID logo *b  

* Corresponding authors

a Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, Guangzhou 510632, China

b College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 500-757, Republic of Korea
E-mail: kmkim@jnu.ac.kr, shcheon@jnu.ac.kr
Fax: +82 625302949
Tel: +82 625302936

c The Fist Affiliated Hospital of Shenzhen University, Shenzhen 518035, China

d Chemical Biology Research at School of Pharmaceutical sciences, Wenzhou Medical University, Wenzhou 325035, China
E-mail: szwzz001@163.com
Fax: +86 75525622938
Tel: +86 75525622938

Abstract

Correction for 'Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists' by Yongkai Cao et al., Med. Chem. Commun., 2018, DOI: 10.1039/c8md00237a.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C8MD90042F
Article type
Correction
Submitted
03 Sep 2018
Accepted
03 Sep 2018
First published
11 Sep 2018
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2018,9, 1565-1565

Permissions

Request permissions

Correction: Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists

Y. Cao, N. Sun, J. Zhang, Z. Liu, Y. Tang, Z. Wu, K. Kim and S. H. Cheon, Med. Chem. Commun., 2018, 9, 1565 DOI: 10.1039/C8MD90042F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements